X-Vax Technology Private
X-Vax Technology is a biotechnology company focused on the preclinical and clinical development of vaccines against pathogens that cause mucosal infections such as herpes, influenza, tuberculosis and HIV, affecting hundreds of millions of people around the globe. They believe that inducing antibodies that mediate the killing of infected cells will provoke an entirely new and effective immune response вАУ so that they can finally beat these pathogens. The company was founded in 2015 and based in Jupiter, Florida.
Total Funding:
56000000
Investor Type:
Early Stage Venture
Last Funding Type:
Series A
Estimated Revenue:
Less than $1M
Founded Date:
2015
Industry:
PharmTech
Employee Number:
11-50
Last Funding Date:
2019
Headquarters:
Jupiter, Florida, United States
Investors Number:
7